7-16258455-G-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001101426.4(CRPPA):​c.1054C>A​(p.Gln352Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00233 in 1,603,468 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 9 hom. )

Consequence

CRPPA
NM_001101426.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.780
Variant links:
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA-AS1 (HGNC:48962): (CRPPA antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002675265).
BP6
Variant 7-16258455-G-T is Benign according to our data. Variant chr7-16258455-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 198766.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=6}. Variant chr7-16258455-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00243 (3524/1451372) while in subpopulation NFE AF= 0.00302 (3344/1106488). AF 95% confidence interval is 0.00294. There are 9 homozygotes in gnomad4_exome. There are 1722 alleles in male gnomad4_exome subpopulation. Median coverage is 28. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CRPPANM_001101426.4 linkc.1054C>A p.Gln352Lys missense_variant 8/10 ENST00000407010.7 NP_001094896.1 A4D126-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CRPPAENST00000407010.7 linkc.1054C>A p.Gln352Lys missense_variant 8/105 NM_001101426.4 ENSP00000385478.2 A4D126-1

Frequencies

GnomAD3 genomes
AF:
0.00140
AC:
213
AN:
151978
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000850
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00232
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00137
AC:
327
AN:
238306
Hom.:
0
AF XY:
0.00142
AC XY:
184
AN XY:
129224
show subpopulations
Gnomad AFR exome
AF:
0.000137
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.000723
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000313
Gnomad FIN exome
AF:
0.000427
Gnomad NFE exome
AF:
0.00268
Gnomad OTH exome
AF:
0.00104
GnomAD4 exome
AF:
0.00243
AC:
3524
AN:
1451372
Hom.:
9
Cov.:
28
AF XY:
0.00239
AC XY:
1722
AN XY:
721608
show subpopulations
Gnomad4 AFR exome
AF:
0.000242
Gnomad4 AMR exome
AF:
0.000115
Gnomad4 ASJ exome
AF:
0.000620
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000249
Gnomad4 FIN exome
AF:
0.000776
Gnomad4 NFE exome
AF:
0.00302
Gnomad4 OTH exome
AF:
0.00145
GnomAD4 genome
AF:
0.00140
AC:
213
AN:
152096
Hom.:
0
Cov.:
32
AF XY:
0.00121
AC XY:
90
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.000458
Gnomad4 AMR
AF:
0.000197
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000850
Gnomad4 NFE
AF:
0.00233
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000548
Hom.:
0
Bravo
AF:
0.00139
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.000554
AC:
2
ESP6500EA
AF:
0.00233
AC:
19
ExAC
AF:
0.00196
AC:
236
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingAthena DiagnosticsMar 17, 2020- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 18, 2021- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2024CRPPA: BP4 -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 23, 2016- -
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Congenital Muscular Dystrophy, alpha-dystroglycan related Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
13
DANN
Benign
0.86
DEOGEN2
Benign
0.0064
T;.
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.057
N
LIST_S2
Benign
0.61
T;T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.0027
T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
1.8
L;.
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.070
N;N
REVEL
Benign
0.060
Sift
Benign
0.59
T;T
Sift4G
Benign
0.90
T;T
Polyphen
0.085
B;.
Vest4
0.18
MVP
0.49
MPC
0.070
ClinPred
0.0012
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.16
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs185594460; hg19: chr7-16298080; API